Expression of substance P, neurokinin-1 receptor and immune markers in the brains of individuals with HIV-associated neuropathology

Journal of the Neurological Sciences

Volumn 334, Issue 1-2, 2013, Pages 18-23

  Spitsin, Sergei ^a   Stevens, Kathleen E ^a   Douglas, Steven D ^a,b  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Brain; HIV; HIVE; Neurokinin 1 receptor; Neuropathology; Substance P

Indexed keywords

CD163 ANTIGEN; CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; FRACTALKINE; GAMMA INTERFERON; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; NEUROKININ 1 RECEPTOR; PREPROTACHYKININ; RANTES; SUBSTANCE P; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BRAIN; CONTROLLED STUDY; FRONTAL CORTEX; GENE EXPRESSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; NEUROPATHOLOGY; PRIORITY JOURNAL; VIRUS LOAD;

BRAIN; HIV; HIVE; NEUROKININ-1 RECEPTOR; NEUROPATHOLOGY; SUBSTANCE P;

ADULT; AIDS-ASSOCIATED NEPHROPATHY; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BIOLOGICAL MARKERS; FEMALE; FRONTAL LOBE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; MALE; MIDDLE AGED; RECEPTORS, CELL SURFACE; RECEPTORS, NEUROKININ-1; SUBSTANCE P; VIRAL LOAD;

EID: 84887422990     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2013.07.008     Document Type: Article

References (55)

1. H. Budka, C.A. Wiley, P. Kleihues, J. Artigas, A.K. Asbury, and E.S. Cho HIV-associated disease of the nervous system: review of nomenclature and proposal for neuropathology-based terminology Brain Pathol 1 3 1991 143 152
2. B.B. Gelman, J.G. Lisinicchia, S. Morgello, E. Masliah, D. Commins, and C.L. Achim Neurovirological correlation with HIV-associated neurocognitive disorders and encephalitis in a HAART-era cohort J Acquir Immune Defic Syndr 62 5 2013 487 495
3. I. Everall, F. Vaida, N. Khanlou, D. Lazzaretto, C. Achim, and S. Letendre Cliniconeuropathologic correlates of human immunodeficiency virus in the era of antiretroviral therapy J Neurovirol 15 5-6 2009 360 370
4. M. Cherner, E. Masliah, R.J. Ellis, T.D. Marcotte, D.J. Moore, and I. Grant Neurocognitive dysfunction predicts postmortem findings of HIV encephalitis Neurology 59 10 2002 1563 1567
5. S. Morgello, R. Mahboob, T. Yakoushina, S. Khan, and K. Hague Autopsy findings in a human immunodeficiency virus-infected population over 2 decades: influences of gender, ethnicity, risk factors, and time Arch Pathol Lab Med 126 2 2002 182 190
6. N. Sacktor, R.H. Lyles, R. Skolasky, C. Kleeberger, O.A. Selnes, and E.N. Miller HIV-associated neurologic disease incidence changes: multicenter AIDS Cohort Study, 1990-1998 Neurology 56 2 2001 257 260
7. K.A. Jellinger, U. Setinek, M. Drlicek, G. Bohm, A. Steurer, and F. Lintner Neuropathology and general autopsy findings in AIDS during the last 15 years Acta Neuropathol 100 2 2000 213 220
8. F. Gray, F. Chretien, A.V. Vallat-Decouvelaere, and F. Scaravilli The changing pattern of HIV neuropathology in the HAART era J Neuropathol Exp Neurol 62 5 2003 May 429 440
9. N.K. Dhillon, R. Williams, S. Callen, C. Zien, O. Narayan, and S. Buch Roles of MCP-1 in development of HIV-dementia Front Biosci 13 2008 3913 3918
10. N. Tong, S.W. Perry, Q. Zhang, H.J. James, H. Guo, and A. Brooks Neuronal fractalkine expression in HIV-1 encephalitis: roles for macrophage recruitment and neuroprotection in the central nervous system J Immunol 164 3 2000 1333 1339
11. E.A. Eugenin, K. Osiecki, L. Lopez, H. Goldstein, T.M. Calderon, and J.W. Berman CCL2/monocyte chemoattractant protein-1 mediates enhanced transmigration of human immunodeficiency virus (HIV)-infected leukocytes across the blood-brain barrier: a potential mechanism of HIV-CNS invasion and NeuroAIDS J Neurosci 26 4 2006 1098 1106
12. S.L. Wesselingh, K. Takahashi, J.D. Glass, J.C. McArthur, J.W. Griffin, and D.E. Griffin Cellular localization of tumor necrosis factor mRNA in neurological tissue from HIV-infected patients by combined reverse transcriptase/polymerase chain reaction in situ hybridization and immunohistochemistry J Neuroimmunol 74 1-2 1997 1 8
13. N.A. Brabers, and H.S. Nottet Role of the pro-inflammatory cytokines TNF-alpha and IL-1beta in HIV-associated dementia Eur J Clin Invest 36 7 2006 447 458
14. E.N. Benveniste Cytokine circuits in brain. Implications for AIDS dementia complex Res Publ Assoc Res Nerv Ment Dis 72 1994 71 88
15. A. Yadav, and R.G. Collman CNS inflammation and macrophage/microglial biology associated with HIV-1 infection J Neuroimmune Pharmacol 4 4 2009 430 447
16. S.D. Kraft-Terry, A.R. Stothert, S. Buch, and H.E. Gendelman HIV-1 neuroimmunity in the era of antiretroviral therapy Neurobiol Dis 37 3 2010 542 548
17. B.B. Gelman, T. Chen, J.G. Lisinicchia, V.M. Soukup, J.R. Carmical, and J.M. Starkey The National NeuroAIDS Tissue Consortium brain gene array: two types of HIV-associated neurocognitive impairment PLoS One 7 9 2012 e46178
18. V. Yuferov, A. Ho, S. Morgello, Y. Yang, J. Ott, and M.J. Kreek Expression of Ephrin Receptors and Ligands in Postmortem Brains of HIV-Infected Subjects With and Without Cognitive Impairment J Neuroimmune Pharmacol 8 1 2013 333 344
19. X. Liu, M. Jana, S. Dasgupta, S. Koka, J. He, and C. Wood Human immunodeficiency virus type 1 (HIV-1) tat induces nitric-oxide synthase in human astroglia J Biol Chem 277 42 2002 39312 39319
20. E. Polazzi, G. Levi, and L. Minghetti Human immunodeficiency virus type 1 Tat protein stimulates inducible nitric oxide synthase expression and nitric oxide production in microglial cultures J Neuropathol Exp Neurol 58 8 1999 825 831
21. A.B. Ragin, Y. Wu, R. Ochs, H. Du, L.G. Epstein, and K. Conant Marked relationship between matrix metalloproteinase 7 and brain atrophy in HIV infection J Neurovirol 17 2 2011 153 158
22. A.B. Ragin, Y. Wu, R. Ochs, R. Scheidegger, B.A. Cohen, and J.C. McArthur Serum matrix metalloproteinase levels correlate with brain injury in human immunodeficiency virus infection J Neurovirol 15 3 2009 275 281
23. S.D. Douglas, K.G. Lynch, and J.P. Lai Neurokinin-1 receptor mRNA expression differences in brains of HIV-infected individuals J Neurol Sci 272 1-2 2008 174 177
24. T.M. Fong, S.A. Anderson, H. Yu, R.R. Huang, and C.D. Strader Differential activation of intracellular effector by two isoforms of human neurokinin-1 receptor Mol Pharmacol 41 1 1992 24 30
25. L. Caberlotto, Y.L. Hurd, P. Murdock, J.P. Wahlin, S. Melotto, and M. Corsi Neurokinin 1 receptor and relative abundance of the short and long isoforms in the human brain Eur J Neurosci 17 9 2003 1736 1746
26. F. Tuluc, J.P. Lai, L.E. Kilpatrick, D.L. Evans, and S.D. Douglas Neurokinin 1 receptor isoforms and the control of innate immunity Trends Immunol 30 6 2009 271 276
27. S.K. Bohm, L.M. Khitin, S.P. Smeekens, E.F. Grady, D.G. Payan, and N.W. Bunnett Identification of potential tyrosine-containing endocytic motifs in the carboxyl-tail and seventh transmembrane domain of the neurokinin 1 receptor J Biol Chem 272 4 1997 2363 2372
28. H. Li, S.E. Leeman, B.E. Slack, G. Hauser, W.S. Saltsman, and J.E. Krause A substance P (neurokinin-1) receptor mutant carboxyl-terminally truncated to resemble a naturally occurring receptor isoform displays enhanced responsiveness and resistance to desensitization Proc Natl Acad Sci U S A 94 17 1997 9475 9480
29. N. Sasakawa, M. Sharif, and M.R. Hanley Attenuation of agonist-induced desensitization of the rat substance P receptor by progressive truncation of the C-terminus FEBS Lett 347 2-3 1994 181 184
30. J.P. Lai, S. Lai, F. Tuluc, M.F. Tansky, L.E. Kilpatrick, and S.E. Leeman Differences in the length of the carboxyl terminus mediate functional properties of neurokinin-1 receptor Proc Natl Acad Sci U S A 105 34 2008 12605 12610
31. E. Thornton, and R. Vink Treatment with a substance P receptor antagonist is neuroprotective in the intrastriatal 6-hydroxydopamine model of early Parkinson's disease PLoS One 7 4 2012 e34138
32. V.S. Chauhan, J.M. Kluttz, K.L. Bost, and I. Marriott Prophylactic and therapeutic targeting of the neurokinin-1 receptor limits neuroinflammation in a murine model of pneumococcal meningitis J Immunol 186 12 2011 7255 7263
33. P.G. Kennedy, J. Rodgers, B. Bradley, S.P. Hunt, G. Gettinby, and S.E. Leeman Clinical and neuroinflammatory responses to meningoencephalitis in substance P receptor knockout mice Brain 126 Pt 7 2003 1683 1690
34. E. Salisbury, E. Rodenberg, C. Sonnet, J. Hipp, F.H. Gannon, and T.J. Vadakkan Sensory nerve induced inflammation contributes to heterotopic ossification J Cell Biochem 112 10 2011 2748 2758
35. M.H. Jiang, E. Chung, G.F. Chi, W. Ahn, J.E. Lim, and H.S. Hong Substance P induces M2-type macrophages after spinal cord injury NeuroReport 23 13 2012 786 792
36. D.E. Campbell, P. Bruckner, N.B. Tustin, R. Tustin III, and S.D. Douglas Novel method for determination of substance P levels in unextracted human plasma by using acidification Clin Vaccine Immunol 16 4 2009 594 596
37. S. Palmer, A.P. Wiegand, F. Maldarelli, H. Bazmi, J.M. Mican, and M. Polis New real-time reverse transcriptase-initiated PCR assay with single-copy sensitivity for human immunodeficiency virus type 1 RNA in plasma J Clin Microbiol 41 10 2003 4531 4536
38. B.B. Gelman, and D.J. Moore H.E. Gendelman, I. Grant, I.P. Everall, H.S. Fox, H.A. Gelbard, S.A. Lipton, S. Swindells, HIV-1 Neuropathology 2012 The Neurology of AIDS Oxford 518 535
39. A.W. Ansari, H. Heiken, D. Meyer-Olson, and R.E. Schmidt CCL2: a potential prognostic marker and target of anti-inflammatory strategy in HIV/AIDS pathogenesis Eur J Immunol 41 12 2011 3412 3418
40. J.D. Glass, H. Fedor, S.L. Wesselingh, and J.C. McArthur Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia Ann Neurol 38 5 1995 755 762
41. T.H. Burdo, M.R. Lentz, P. Autissier, A. Krishnan, E. Halpern, and S. Letendre Soluble CD163 made by monocyte/macrophages is a novel marker of HIV activity in early and chronic infection prior to and after anti-retroviral therapy J Infect Dis 204 1 2011 154 163
42. E. Tippett, W.J. Cheng, C. Westhorpe, P.U. Cameron, B.J. Brew, and S.R. Lewin Differential expression of CD163 on monocyte subsets in healthy and HIV-1 infected individuals PLoS One 6 5 2011 e19968
43. T.H. Burdo, J. Lo, S. Abbara, J. Wei, M.E. DeLelys, and F. Preffer Soluble CD163, a novel marker of activated macrophages, is elevated and associated with noncalcified coronary plaque in HIV-infected patients J Infect Dis 204 8 2011 1227 1236
44. S. Subramanian, A. Tawakol, T.H. Burdo, S. Abbara, J. Wei, and J. Vijayakumar Arterial inflammation in patients with HIV JAMA 308 4 2012 379 386
45. H. Vinet-Oliphant, X. Alvarez, E. Buza, J.T. Borda, M. Mohan, and P.P. Aye Neurokinin-1 receptor (NK1-R) expression in the brains of SIV-infected rhesus macaques: implications for substance P in NK1-R immune cell trafficking into the CNS Am J Pathol 177 3 2010 1286 1297
46. L. Schwartz, S.V. Spitsin, J. Meshki, F. Tuluc, S.D. Douglas, and J.H. Wolfe Substance P enhances HIV-1 infection in human fetal brain cell cultures expressing full-length neurokinin-1 receptor J Neurovirol 19 3 2013 219 227
47. S.D. Douglas, A. Cnaan, K.G. Lynch, T. Benton, H. Zhao, and D.R. Gettes Elevated substance P levels in HIV-infected women in comparison to HIV-negative women AIDS Res Hum Retroviruses 24 3 2008 375 378
48. S.D. Douglas, W.Z. Ho, D.R. Gettes, A. Cnaan, H. Zhao, and J. Leserman Elevated substance P levels in HIV-infected men AIDS 15 15 2001 2043 2045
49. P. Annunziata, C. Cioni, R. Santonini, and E. Paccagnini Substance P antagonist blocks leakage and reduces activation of cytokine-stimulated rat brain endothelium J Neuroimmunol 131 1-2 2002 41 49
50. P. Annunziata, C. Cioni, S. Toneatto, and E. Paccagnini HIV-1 gp120 increases the permeability of rat brain endothelium cultures by a mechanism involving substance P AIDS 12 18 1998 2377 2385
51. S.D. Douglas, J.P. Lai, F. Tuluc, L. Schwartz, and L.E. Kilpatrick Neurokinin-1 receptor expression and function in human macrophages and brain: perspective on the role in HIV neuropathogenesis Ann N Y Acad Sci 1144 2008 90 96
52. O. Berton, H.E. Covington III, K. Ebner, N.M. Tsankova, T.L. Carle, and P. Ulery Induction of deltaFosB in the periaqueductal gray by stress promotes active coping responses Neuron 55 2 2007 289 300
53. V. Vialou, A.J. Robison, Q.C. Laplant, H.E. Covington III, D.M. Dietz, and Y.N. Ohnishi DeltaFosB in brain reward circuits mediates resilience to stress and antidepressant responses Nat Neurosci 13 6 2010 745 752
54. C.A. Winstanley, Q. LaPlant, D.E. Theobald, T.A. Green, R.K. Bachtell, and L.I. Perrotti DeltaFosB induction in orbitofrontal cortex mediates tolerance to cocaine-induced cognitive dysfunction J Neurosci 27 39 2007 10497 10507
55. C. Bardelli, A. Amoruso, E. Manzetti, L.G. Fresu, R. Valsesia, and P. Zeppegno Recurrent major depressive disorder: imbalance of neurokinin (NK)-1 and NK-2 receptor expression in monocytes Pharmacol Res 68 1 2013 24 30